P. Wolkenstein

SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis

Nathalie Fouchard, M. Bertocchi, Jean‐Claude Roujeau et al. · Journal of Investigative Dermatology · 2000 · 1.2K citations · Full text

Toxic Epidermal Necrolysis, Clinical Dermatology, Wound Healing +4

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation

Eric Legius, Ludwine Messiaen, P. Wolkenstein et al. · Genetics in Medicine · 2021 · 687 citations · Full text

Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

J. Revuz, Florence Canouï‐Poitrine, P. Wolkenstein et al. · Journal of the American Academy of Dermatology · 2008 · 614 citations

Allergy, Clinical Dermatology, Dermatology +5

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

P. Wolkenstein, J Latarjet, Jean‐Claude Roujeau et al. · The Lancet · 1998 · 424 citations

Toxic Epidermal Necrolysis, Pharmacology, Toxicology +5

Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells

Amal Nassif, Armand Bensussan, Laurence Boumsell et al. · Journal of Allergy and Clinical Immunology · 2004 · 401 citations

Inflammation, Toxic Epidermal Necrolysis, Immunotoxicology +7